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Abstract
Cancer is characterized by genomic complexity and chromosomal instability (CIN). 
Atypical mitosis and nuclear atypia such as micronuclei have been reported as morpho-
logical characteristics of chromosomal instability. An atypical mitotic figure is defined 
as anything other than the typical form of normal mitosis, including multipolar, ring, 
dispersed, asymmetrical, and lag-type mitoses. A micronucleus is defined as the small 
nucleus that forms whenever a chromosome or its fragment is not incorporated into one 
of the daughter nuclei during cell division. A telomere plays a key role in chromosomal 
instability. Telomere dysfunction induces fusion of chromatids and chromosome misseg-
regation and this phenomenon can be observed as abnormal mitotic figures and micronu-
clei. Detection of morphological markers of chromosomal instability using pathological 
specimens, even small biopsy or cytological specimens, may provide valuable informa-
tion concerning the prognosis of cancers. Here, we discuss morphological assessment of 
chromosomal instability using routine pathological specimens.
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1. Introduction
Cancer is characterized by genomic complexity and chromosomal instability (CIN); muta-
tions of cancer-related genes, telomere dysfunction, aneuploidy, polyploidy, nuclear atypia, 
and abnormal mitosis are all contributors to this phenotype [1–4]. The greatest risk factor for 
cancer is considered to be aging, via telomere shortening, accumulation of mutations, and per-
turbations in the microenvironment [5, 6]. Previously, we showed that age-related shortening 
of telomere length in various tissues is correlated to aging-related diseases, such as cancers, 
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diabetes mellitus, and cognitive disorders [7]. Telomere shortening often occurs in cancers, 
as well as in precancerous lesions [8–10]. Telomere shortening induces fusion of chromatids 
and chromosome missegregation and this phenomenon can be observed as abnormal mitotic 
figures and micronuclei. In this article, we discuss the morphological markers to determine 
chromosomal instability in cancer tissues.
2. Chromosomal instability
CIN is defined as a persistently high rate of loss or gain of full or partial chromosomes 
induced by defects in cohesion, the spindle assembly checkpoint, centrosomes, kinetochore-
microtubule attachment dynamics, or cell cycle regulation [11, 12]. Cells with CIN make 
errors in chromosome segregation in approximately 20% of cell divisions and the unequal 
distribution of DNA to daughter cells upon mitosis induces a failure to maintain euploidy 
leading to aneuploidy. Most solid tumors and hematological cancers are aneuploidy and 
many missegregate chromosomes at very high rates [11]. However, the presence of aneu-
ploidy in cells does not necessarily mean CIN is present; a high rate of errors is definitive 
of CIN. Detection of CIN requires the determination of chromosome missegregation rates, 
however the ability to detect CIN from fixed tumor tissues is limited [13]. Therefore, when we 
need to determine CIN using fixed tumor samples in the clinical setting, we usually perform 
indirect methods such as karyotype analysis, fluorescent in situ hybridization, or array-based 
comparative genomic hybridization analyses. Analysis of atypical mitotic figures and nuclear 
atypia is considered a useful method to distinguish chromosomally unstable from chromo-
somally stable malignancies [14–18].
3. Mitotic figures
Mitosis is divided into five stages: prophase, prometaphase, metaphase, anaphase, and telo-
phase. During mitosis, chromosomes thicken and condense, allowing them to be visualized 
by light microscopy. Most malignant tumors show a high mitotic index and for some tumors, 
a diagnosis of malignancy is based on mitotic index. A higher mitotic index is correlated with 
malignancy grade and prognosis [19, 20]. Structural chromosomal abnormalities may arise 
during somatic cell divisions. Cells with CIN have a higher probability of causing chromo-
some missegregation during mitosis as compared to normal cells, suggesting a close relation-
ship between high mitotic index and CIN in malignancies, possibly as a result of mitotic arrest 
as opposed to high frequency of mitoses.
Cytological smears and formalin-fixed paraffin-embedded tissue samples are useful materials 
for evaluating mitotic figures because they are routinely performed in laboratories around the 
world. Metaphase figures can be evaluated using hematoxylin and eosin (H&E), Giemsa, or 
Papanicolaou-stained slides examined at high power magnification. The mitotic index value is 
assessed by counting the number of mitoses per 1000 or 2000 nuclei or per 50 high power fields. 
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Mitotic figures are defined as figures without a nuclear membrane, which indicates that the 
cell has passed prophase and in which clear hairy extensions of nuclear material are present. 
Pyknotic nuclei or nuclei with basophilic cytoplasm are not thought to distinguish mitosis from 
apoptosis or degenerative cells [21]. Recently, immunohistochemical determination of prolifer-
ating cells using primary antibodies for Ki67, PCNA, or phosphohistone H3 has become popu-
lar; however, sometimes there is a discrepancy between mitotic index and Ki67 index [22–24]. 
We believe that this phenomenon represents the frequent mitotic arrest mentioned above.
4. Atypical mitosis
Mitosis is classified into normal and atypical mitosis [25]. An atypical mitotic figure is defined 
as anything other than the typical form of normal mitosis, including an anaphase bridge, mul-
tipolar, ring, dispersed, asymmetrical, and lag-type mitoses [25, 26] (Figure 1). Cells in mitosis 
are often seen in normal tissues exhibiting rapid turnover, such as the epithelium of the gut, 
but the most important morphologic features of malignancy are atypical and bizarre mitotic 
figures. In our analysis, 30% of mitosis in pancreatic cancer cells was atypical mitosis, while 
normal epithelium did not show atypical mitosis and precancerous lesions showed only a few 
instances of atypical mitosis [9, 18].
An anaphase bridge is defined as a filamentous connection linking two well-separated and 
parallel-aligned groups of anaphase chromosomes [14, 15]. Telomeres protect each end of the 
chromosome from fusion; therefore, telomere dysfunction can be observed as an anaphase 
bridge [15, 17]. A lot of evidence has shown that telomere dysfunction plays a key role in 
carcinogenesis via induction of CIN [9, 27]; thus, detection of an anaphase bridge has been 
considered a useful method of indirectly evaluating telomere dysfunction and CIN.
Figure 1. Normal and atypical mitosis in cancer cells. A, normal mitosis; B, anaphase bridge; C, multipolar mitosis; D, 
ring mitosis; E, dispersed mitosis; F, asymmetrical mitosis; G, lag-type mitosis; and H, micronuclei. H&E stain. Original 
magnification 400×.
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Multipolar mitosis is metaphase with an abnormal configuration of the equatorial plate 
and the chromosomes are located along several radial axes. These figures are subdivided 
into tripolar mitoses, quadripolar mitoses, and others. Multipolar mitosis might be associ-
ated with multipolar spindles and numerical and functional abnormalities of centrosomes 
[28, 29]. It has been reported that multipolar mitosis determined by cytologic smears is useful 
to distinguish malignancies from benign tissue [30, 31]. Recently, we have reported that the 
existence of multipolar mitosis, but not other atypical mitotic figures, was an independent 
prognostic factor for in pancreatic cancers [18]. Multipolar mitosis-positive pancreatic cancer 
cases may have high invasiveness into surrounding tissue and arteries, in part, because of 
chromosomal instability and abnormality of the centrosome.
Lag-type mitoses are figures with nonattached condensed chromatin in the area of the mitotic 
figure. These are subdivided into metaphases with nonattached condensed chromatin at one 
polar side, metaphases with nonattached condensed chromatin at equidistant positions at the 
two polar sides and others. Furuta et al. has reported lag-type mitosis as a marker of high-risk 
human papilloma virus associated cervical cancers [32].
Medication-induced atypical mitoses have been reported. Docetaxel, paclitaxel, and colchi-
cine can cause mitotic arrest, ring mitoses, and epithelial atypia mimicking dysplasia [33, 34]. 
They bind to the β-tubulin subunit of the microtubules of the mitotic spindle apparatus and 
therefore prevent mitotic spindle formation.
The interrelationship of each atypical mitotic figure has not been well clarified; however, each 
type of atypical mitosis is a morphologically important marker of CIN.
5. Telomere dysfunction
Aging drives telomere dysfunction. Inflammation, alcohol drinking, and diabetes mellitus 
also accelerate telomere attrition [35–37]. Furthermore, telomere shortening initiates the early 
phase of carcinogenesis even when there are no histopathological changes [9, 17]. Telomere 
dysfunction can be seen as nuclear atypia including the presence of micronuclei, nuclear buds, 
and anaphase bridges [38]. In our analysis, telomere length in the normal pancreatic duct was 
negatively correlated with mitotic index [9], which is consistent with telomere shortening of 
100 base pairs in each mitosis. Normal epithelial cells in pancreatic cancer patients showed 
shorter telomeres than those in patients without cancers. Furthermore, telomere shortening 
was correlated to KRAS mutation in pancreatic cancer. These data indicate that telomere short-
ening occurs prior to CIN and drives CIN [39]. As a result, CIN drives gene mutation, deletion, 
or amplification.
In addition to this pathway, microsatellite instability also induces genetic abnormality and 
there seems to be organ specificity. Some colon and uterine cancers are caused by microsatel-
lite instability [40], but most pancreatic cancers are microsatellite stable. All of the conven-
tional pancreatic ductal adenocarcinomas showed telomere dysfunction and it progressed 
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according to malignancy grade of pancreatic carcinogenesis steps [9]. Organ specificity as 
well as the difference of carcinogens might influence such difference of carcinogenesis steps. 
In CIN cancers, mitosis and atypical mitosis might have a predictive value of malignancy 
grade and prognosis [18].
6. Morphological markers of chromosomal instability
The usefulness of micronuclei in distinguishing malignant lesions from benign lesions 
using cytological specimens has been well clarified [41–43]. A micronucleus is the small 
nucleus that forms whenever a chromosome or its fragment is not incorporated into one 
of the daughter nuclei during cell division and it serves as an indicator of CIN. Samanta 
et al. reported that in the evaluation of the number of micronuclei in 1000 cells from fine 
needle aspiration samples of the breast, cancer cells showed a higher number of micronu-
clei than benign lesions [44]. Tyagi et al. assessed the number of anaphase bridges, multi-
polar mitoses, micronuclei, and nuclear budding in 1000 cells in Giemsa stained smears of 
ascitic fluid and found that these markers were correlated with the cytological diagnosis 
[30]. Moreover, Verma and Dey counted anaphase bridges, multipolar mitoses per smear, 
micronuclei and nuclear budding per 1000 carcinoma cells using fine needle aspiration 
samples of breast cancer and these markers were correlated with cytological grades [31]. 
We also counted normal and atypical mitoses in 1000 cells using surgically resected pan-
creatic cancer tissues and they were correlated with tumor stage and prognosis [18]. The 
number of mitotic figures is sometimes very low even in cancer tissues. For example, the 
mitotic index of pancreatic cancers was only 0.4%, suggesting the potential need to analyze 
more than 1000 cells [45].
Micronuclei, nuclear budding, anaphase bridging, and multipolar mitoses have been well 
evaluated among various morphological markers of CIN. The molecular methods to deter-
mine CIN are costly, require expertise, and may not be available in many laboratories. In 
the future, these aforementioned markers can be applied to diagnose malignancy in difficult 
cases of suspected malignancy.
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